CoChat

Probiotics in the treatment of vaginal infections: efficacy from the perspective of evidence-based medicine

Open access
Leonova, M. V. · 2020 · Meditsinskiy sovet = Medical Council

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

The problem of vaginal infections in women (BV and VVC) remains relevant due to both the high prevalence and the lack of effectiveness of antimicrobial therapy and the risk of recurrence. One solution is to use probiotics, in particular probiotic lactobacilli that protect the vaginal environment from pathogens. The group of vaginal lactobacteria is dominated by L. crispatus, L. iners, L. jensenii, L. gasseri. Lactobacteria in the vaginal environment provide important protective functions against pathogens due to the production of lactic and other organic acids that maintain pH < 4.5, high ability to adhere to epithelium and aggregation, with the formation of biofilm and biosurfactants, inhibition of binding and adhesion of pathogenic bacteria, as well as products of antimicrobial substances such as H2O2, bacteriocins, and regulation of local epithelial immunity. Probiotic lactobacteria can be used both vaginally and orally, effectively colonizing the vaginal environment. Several meta-analyses of randomized clinical trials (RCTs) were performed to evaluate the efficacy of probiotics in combination with antibiotics and in monotherapy. The efficacy of probiotics in BV was confirmed in 4 meta-analyses, which showed a significant increase in the frequency of treatment (RR more than 1.53), including in monotherapy without antibiotics (RR more than 2.57). The efficiency of probiotics in oral use exceeded vaginal forms. In one meta-analysis of RCTs the efficacy of probiotic lactobacteria in VVC was confirmed both in achieving a higher cure rate in oral and vaginal use (RR 1,41 and RR 1,11 respectively), and in reducing the frequency of relapse (RR 0,34). Probiotics are included in clinical recommendations of the USA, Canada with the level of evidence I-II, as well as in domestic recommendations as the second stage of treatment after antimicrobial therapy. Thus, the use of probiotics represents an alternative strategy and helps to improve treatment results through the restoration of the vaginal ecosystem.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.21518/2079-701x-2020-13-148-154

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 4

  1. BLostein F., Levin-Sparenberg E., Wagner J., Foxman B. Recurrent vuLvovaginaL candidiasis. Ann Epidemiol. 2017;27(9):575-582. doi: 10.1016/j.annep-idem.2017.08.010. · doi:10.1016/j.annep-idem.2017.08.010
  2. Ventolini G. Update on vaginal Lactobacilli and biofilm formation. J Bacteriol Mycol. 2014;1(1):2 Available at: https://austinpublishinggroup. com/bacteriology/fulltext/bacteriology-v1-id1001.php.
  3. Mastromarino P, Vitali B., Mosca L. Bacterial vaginosis: a review on clinical trials with probiotics. New Microbiol. 2013;36(3):229-238. Available at: https://pubmed.ncbi.nlm.nih.gov/23912864/.
  4. Dhewa T., Bajpai V., Saxena R.K., Pant S., Mishra V. Selection of lactobacillus strains as potential probiotics on basis of in vitro attributes. Int J Probiotics Prebiotics. 2010;5(1):45-52. Available at: http://www.nchpjour-nals.com/admin/uploads/article_811.pdf.

Cited by

See all 4

Metadata

Authors
Leonova, M. V.
Affiliations
Association of Clinical Pharmacologists of Russia
Venue
Meditsinskiy sovet = Medical Council
Published
2020-10-13
Issue
13
Pages
148-154
ISSN
  • 2079-701X (ISSN-L)
  • 2658-5790
OpenAlex
W3154992711
Cited by
4
References
34
Citations by year
2025: 3 · 2024: 1
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Meditsinskiy sovet = Medical Council (publishedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Meditsinskiy sovet = Medical Council (submittedVersion, cc-by-nc-nd)
Topics
  • Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
probiotics, vaginal infection, bacterial vaginosis, vaginal candidiasis, vaginal lactobacilli, Lactobacillus crispatus, Lactobacillus iners, Lactobacillus jensenii, Lactobacillus gasseri, recurrence prevention, vaginal microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotics in the treatment of vaginal infections: efficacy from the perspective of evidence-based medicine. https://app.cochat.ai/papers/10.21518/2079-701x-2020-13-148-154
The paper
Leonova, M. V. (2020). Probiotics in the treatment of vaginal infections: efficacy from the perspective of evidence-based medicine. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/2079-701x-2020-13-148-154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.